Literature DB >> 18422603

Stau1 negatively regulates myogenic differentiation in C2C12 cells.

Yukio Yamaguchi1, Remi Oohinata, Takahiro Naiki, Kenji Irie.   

Abstract

Sequential expression of myogenic regulatory factors (MRFs) such as MyoD and myogenin drives myogenic differentiation. Besides transcriptional activation of MRFs, this process is also coordinated by post-transcriptional regulation; MyoD and myogenin mRNAs are stabilized by RNA-binding protein HuR. Stau1 is known to regulate mRNA stability in a complex with Upf1, which is termed Stau1-mediated mRNA decay (SMD). We describe here that Stau1 is involved in the regulation of myogenesis. We found that knockdown of Stau1 promotes myogenesis including the expression of a muscle-specific marker protein, myoglobin, in C2C12 myoblasts. MyoD induces myogenin expression in response to induction of myogenesis, which is a key step to start myogenesis. The level of MyoD protein was not affected when Stau1 was depleted by siRNA, whereas the levels of myogenin mRNA and protein were increased in Stau1-knockdown cells. Interestingly, myogenin promoter activity was also increased in Stau1-knockdown cells in the absence of induction of myogenesis. Furthermore, Stau1-knockdown cells spontaneously progressed myogenesis including the expression of muscle-specific protein. Although Stau1 is involved in mRNA decay together with Upf1, Upf1-knockdown did not affect progression of myogenesis. Our results suggest that Stau1 negatively regulates myogenesis in C2C12 myoblasts through a mechanism that is different from SMD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422603     DOI: 10.1111/j.1365-2443.2008.01189.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  10 in total

1.  TINCR, staufen1, and cellular differentiation.

Authors:  Markus Kretz
Journal:  RNA Biol       Date:  2013-08-27       Impact factor: 4.652

2.  Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features.

Authors:  Tara E Crawford Parks; Kristen A Marcellus; Christine Péladeau; Bernard J Jasmin; Aymeric Ravel-Chapuis
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

3.  SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs.

Authors:  Chenguang Gong; Yoon Ki Kim; Collynn F Woeller; Yalan Tang; Lynne E Maquat
Journal:  Genes Dev       Date:  2008-12-18       Impact factor: 11.361

4.  Cell cycle-dependent regulation of the RNA-binding protein Staufen1.

Authors:  Karine Boulay; Mehdi Ghram; Wildriss Viranaicken; Véronique Trépanier; Stéphanie Mollet; Céline Fréchina; Luc DesGroseillers
Journal:  Nucleic Acids Res       Date:  2014-06-06       Impact factor: 16.971

5.  Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events.

Authors:  Tara E Crawford Parks; Kristen A Marcellus; Jonathan Langill; Aymeric Ravel-Chapuis; Jean Michaud; Kyle N Cowan; Jocelyn Côté; Bernard J Jasmin
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

6.  PABPC1-induced stabilization of BDNF-AS inhibits malignant progression of glioblastoma cells through STAU1-mediated decay.

Authors:  Rui Su; Jun Ma; Jian Zheng; Xiaobai Liu; Yunhui Liu; Xuelei Ruan; Shuyuan Shen; Chunqing Yang; Di Wang; Heng Cai; Zhen Li; Yixue Xue
Journal:  Cell Death Dis       Date:  2020-02-03       Impact factor: 8.469

7.  Distinct roles for the RNA-binding protein Staufen1 in prostate cancer.

Authors:  Kristen A Marcellus; Tara E Crawford Parks; Shekoufeh Almasi; Bernard J Jasmin
Journal:  BMC Cancer       Date:  2021-02-04       Impact factor: 4.430

8.  High Level of Staufen1 Expression Confers Longer Recurrence Free Survival to Non-Small Cell Lung Cancer Patients by Promoting THBS1 mRNA Degradation.

Authors:  Florence Bonnet-Magnaval; Leïla Halidou Diallo; Valérie Brunchault; Nathalie Laugero; Florent Morfoisse; Florian David; Emilie Roussel; Manon Nougue; Audrey Zamora; Emmanuelle Marchaud; Florence Tatin; Anne-Catherine Prats; Barbara Garmy-Susini; Luc DesGroseillers; Eric Lacazette
Journal:  Int J Mol Sci       Date:  2021-12-25       Impact factor: 5.923

Review 9.  The multifunctional RNA-binding protein Staufen1: an emerging regulator of oncogenesis through its various roles in key cellular events.

Authors:  Shekoufeh Almasi; Bernard J Jasmin
Journal:  Cell Mol Life Sci       Date:  2021-10-11       Impact factor: 9.261

10.  The RNA-binding protein Staufen1 impairs myogenic differentiation via a c-myc-dependent mechanism.

Authors:  Aymeric Ravel-Chapuis; Tara E Crawford; Marie-Laure Blais-Crépeau; Guy Bélanger; Chase T Richer; Bernard J Jasmin
Journal:  Mol Biol Cell       Date:  2014-09-10       Impact factor: 4.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.